Standout Papers

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with B... 2013 2026 2017 2021 739
  1. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial (2013)
    Michèle Tameris, Mark Hatherill et al. The Lancet

Immediate Impact

1 by Nobel laureates 21 from Science/Nature 57 standout
Sub-graph 1 of 22

Citing Papers

GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
Trained immunity in chronic inflammatory diseases and cancer
2025 Standout
1 intermediate paper

Works of Mark Hatherill being referenced

Bacillus Calmette–Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses
2016
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
2013 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
Mark Hatherill 3891 3033 1825 2188 188 6.4k
David W. Alling 1768 3369 762 1722 121 8.4k
André C. Kalil 2211 4851 689 663 168 8.7k
Andy I. M. Hoepelman 3970 5130 730 1044 255 10.2k
Peter Speelman 3680 3334 1198 1585 138 8.6k
Deepali Kumar 3636 6565 1570 924 230 9.6k
Maurizio de Martino 2379 2418 744 689 240 6.0k
Juan Gea‐Banacloche 1049 3952 1093 1263 103 7.1k
Pekka Saikku 1201 5539 1984 2198 223 12.4k
Robert S. Holzman 2309 2261 1159 665 152 6.1k
Jan Fehr 1974 1378 456 867 192 5.6k

All Works

Loading papers...

Rankless by CCL
2026